LEMD2 and cardiomyopathy: To investigate the molecular mechanisms underlying cardiomyopathy caused by the LEMD2 c.T38>G mutation in humans (20), we generated mice carrying the same mutation, using CRISPR-Cas9 technology (Supplemental Figure 1B).